High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting

[1]  F. Annor,et al.  Correlates of cervical cancer screening participation, intention and self-efficacy among Muslim women in southern Ghana , 2022, BMC Women's Health.

[2]  A. Williamson,et al.  High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention , 2022, PloS one.

[3]  R. Asmah,et al.  Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study , 2021, BMC Women's Health.

[4]  M. Einstein,et al.  Cervical cancer prevention and control in women living with human immunodeficiency virus , 2021, CA: a cancer journal for clinicians.

[5]  F. Zhao,et al.  Performance of cervical cancer screening and triage strategies among women living with HIV in China , 2021, Cancer medicine.

[6]  J. Amuah,et al.  Determining the prevalence of high-risk human papillomavirus infection using a novel cervical precancer screening approach in incarcerated women at the Nsawam Medium Security Prison, Ghana , 2021, Ecancermedicalscience.

[7]  Jude Ogechukwu Okoye,et al.  Prevalence of high-risk HPV genotypes in sub-Saharan Africa according to HIV status: a 20-year systematic review , 2021, Epidemiology and health.

[8]  Tilahun Teklehaymanot,et al.  Knowledge, attitude and practice of cervical cancer screening among women infected with HIV in Africa: Systematic review and meta-analysis , 2021, PloS one.

[9]  J. Ferlay,et al.  Cancer statistics for the year 2020: An overview , 2021, International journal of cancer.

[10]  R. Legood,et al.  Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study , 2021, PloS one.

[11]  S. Delany-Moretlwe,et al.  Diagnostic accuracy of cervical cancer screening and screening–triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study , 2021, PLoS medicine.

[12]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[13]  G. Medhin,et al.  Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis , 2020, Virology Journal.

[14]  Yan Liu,et al.  Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening , 2020, Infectious agents and cancer.

[15]  L. R. Long,et al.  Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage , 2020, Infectious agents and cancer.

[16]  E. Drokow,et al.  Awareness of Cervical Cancer and Attitude Toward Human Papillomavirus and Its Vaccine Among Ghanaians , 2020, Frontiers in Oncology.

[17]  A. Dumont,et al.  Acceptability of HPV screening among HIV-infected women attending an HIV-dedicated clinic in Abidjan, Côte d’Ivoire , 2020, BMC Women's Health.

[18]  D. Katzenstein,et al.  Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe , 2020, BMC Women's Health.

[19]  K. Anastos,et al.  A comparison of screening tests for detection of high-grade cervical abnormalities in women living with HIV from Cameroon , 2020, Infectious Agents and Cancer.

[20]  D. Parkin,et al.  Trends in cervical cancer incidence in sub-Saharan Africa , 2020, British Journal of Cancer.

[21]  K. Anastos,et al.  Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context , 2020, BMC Women's Health.

[22]  O. Mukuku,et al.  Barriers and Facilitators to Cervical Cancer Prevention in Mbuji-Mayi, Democratic Republic of Congo: A Qualitative Study , 2020 .

[23]  S. Franceschi,et al.  Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan , 2020, Emerging infectious diseases.

[24]  Jacques Ferlay,et al.  Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis , 2019, The Lancet. Global health.

[25]  S. Akaba,et al.  Impact of health education intervention on knowledge and perception of cervical cancer and screening for women in Ghana , 2019, BMC Public Health.

[26]  Y. Adu-Sarkodie,et al.  Knowledge and experience of a cohort of HIV-positive and HIV-negative Ghanaian women after undergoing human papillomavirus and cervical cancer screening , 2019, BMC women's health.

[27]  M. Pawlita,et al.  Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana , 2019, PloS one.

[28]  J. Hogan,et al.  A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women , 2019, BMC Infectious Diseases.

[29]  J. V. Geertruyden,et al.  Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control , 2018, bioRxiv.

[30]  E. Udofia,et al.  Correction to: Factors associated with late presentation of cervical cancer cases at a district hospital: a retrospective study , 2018, BMC Public Health.

[31]  Y. Woo,et al.  Healthcare Providers´ Views on Cervical Screening: A Qualitative Study of Barriers to Cervical Screening in Malaysia , 2018, Journal of Global Oncology.

[32]  E. Banks,et al.  Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30-44 years: A case-control study in New South Wales, Australia. , 2018, Cancer epidemiology.

[33]  K. Fontaine,et al.  Awareness and Beliefs About Cervical Cancer, the HPV Vaccine, and Cervical Cancer Screening Among Ghanaian Women with Diverse Education Levels , 2018, Journal of Cancer Education.

[34]  A. Mezlini,et al.  Association of Combined Tobacco Smoking, Hormonal Contraceptive use and Status Matrimonial with Cervical Cancer Evolution in Tunisian Women , 2018, Pathology & Oncology Research.

[35]  N. Ebu.  Facilitators and barriers to cervical cancer screening among HIV-positive women in Ghana , 2018 .

[36]  N. Ebu.  Socio-demographic characteristics influencing cervical cancer screening intention of HIV-positive women in the central region of Ghana , 2018, Gynecologic Oncology Research and Practice.

[37]  N. Ebu,et al.  Predictors of cervical cancer screening intention of HIV-positive women in the central region of Ghana , 2018, BMC Women's Health.

[38]  A. Jemal,et al.  Knowledge about cervical cancer and barriers toward cervical cancer screening among HIV‐positive women attending public health centers in Addis Ababa city, Ethiopia , 2018, Cancer medicine.

[39]  E. Nieboer,et al.  Sociodemographic characteristics, sexual behaviour and knowledge about cervical cancer prevention as risk factors for high-risk human papillomavirus infection in Arkhangelsk, North-West Russia , 2018, International journal of circumpolar health.

[40]  F. Alhamlan,et al.  Human papillomaviruses: The cervical cancer saga in developing countries. , 2017, Journal of infection in developing countries.

[41]  Y. Qiao,et al.  Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis , 2017, The lancet. HIV.

[42]  Y. Adu-Sarkodie,et al.  Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women , 2017, BMC Cancer.

[43]  Sushama D. Acharya,et al.  Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research , 2017, BMJ Open.

[44]  E. Kleppa,et al.  High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: implications for vaccination , 2017, Infectious diseases.

[45]  Y. Adu-Sarkodie,et al.  Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana , 2017, Gynecologic Oncology Research and Practice.

[46]  Y. Traoré,et al.  Molecular Characterization of High-Risk Human Papillomavirus in Women in Bobo-Dioulasso, Burkina Faso , 2016, BioMed research international.

[47]  E. Owusu-Dabo,et al.  Genotypic characterisation of human papillomavirus infections among persons living with HIV infection; a case–control study in Kumasi, Ghana , 2016, Tropical medicine & international health : TM & IH.

[48]  R. Asmah,et al.  Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana , 2016, Infectious Agents and Cancer.

[49]  M. Mercier,et al.  Human papillomavirus genotypes among women with or without HIV infection: an epidemiological study of Moroccan women from the Souss area , 2015, Infectious Agents and Cancer.

[50]  Sylvia C. Mupepi,et al.  Knowledge, practice, and barriers toward cervical cancer screening in Elmina, Southern Ghana , 2014, International journal of women's health.

[51]  A. Ferenczy,et al.  Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. , 2013, The Journal of infectious diseases.

[52]  D. Larsimont,et al.  Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women. , 2013, The Journal of infectious diseases.

[53]  S. Franceschi,et al.  Human papillomavirus, human immunodeficiency virus and immunosuppression. , 2012, Vaccine.

[54]  A. Malpica,et al.  Consistent Condom Use Increases the Regression Rate of Cervical Intraepithelial Neoplasia 2–3 , 2012, PloS one.

[55]  P. Castle,et al.  Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa , 2012, International journal of cancer.

[56]  J. Mei,et al.  Human Papillomavirus Type-Specific Prevalence in Women with Cervical Intraepithelial Neoplasm in Western China , 2011, Journal of Clinical Microbiology.

[57]  R. Rose,et al.  Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN). , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[58]  S. de Sanjosé,et al.  Epidemiology and prevention of human papillomavirus and cervical cancer in sub‐Saharan Africa: a comprehensive review , 2009, Tropical medicine & international health : TM & IH.

[59]  H. Weiss,et al.  Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso , 2006, British Journal of Cancer.

[60]  S. Franceschi,et al.  Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis , 2005, The Lancet.

[61]  E. Unger,et al.  Human Papillomavirus and Cervical Cancer , 2004, Emerging infectious diseases.

[62]  H. Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[63]  K. Holmes,et al.  Cervical Intraepithelial Neoplasia and Human Papillomavirus Infection among Senegalese Women Seropositive for HIV-1 or HIV-2 or Seronegative for HIV , 1994, International journal of STD & AIDS.

[64]  A. Mudigdo,et al.  The Effect of Obesity, Oral Contraceptive and Passive Smoking on the Risk of Cervical Cancer , 2019, Journal of Epidemiology and Public Health.

[65]  J. Palefsky,et al.  Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[66]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[67]  H. zur Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature reviews. Cancer.